This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by de Moraes, M. Articles by Odorico de Moraes, M Search for Related Content PubMed PubMed Citation Articles by de Moraes, M. Articles by Odorico de Moraes, M Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PAREGORIC Social Bookmarking                         What's this?

Safety evaluation of Elixir paregorico® in healthy volunteers: a phase I study

Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil betemora{at}ufc.br

MM Bezerra

Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil

FAF Bezerra

Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil

RA de Moraes

Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil betemora{at}ufc.br

PP Cavalcanti

Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil

CRA Uchoa

Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil

FAV Lima

Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil

M Odorico de Moraes

Department of Physiology and Pharmacology, Faculty of Medicine, Clinical Pharmacology Unit, Federal University of Ceará, Brazil

A liquid alcoholic extract of Papaver somniferum named Elixir Paregorico® is extensively used for diarrheal diseases in Brazil. Its increased popularity has brought concerns and fears over the safety of this herbal product. Given the lack of investigative clinical studies, in this regard, this study investigated whether Elixir Paregorico® administration causes any noticeable toxic effects in healthy volunteers. In all, 28 middle-aged healthy male (n = 14) and female (n = 14) were enrolled. After screening and a washout period, eligible subjects received four oral doses per day of Elixir Paregorico® (3 mL diluted in 30 mL of water) over a 10-day period. Altogether, all 28 participants completed the study. The results of hematological and biochemical tests performed pre and post-treatment were within the normal range. In both male and female volunteers, there were no statistical differences (P > 0.05) in the results of clinical and laboratory tests performed at screening, on 5th and 10th day visits, and at final assessment. Although mild adverse events were related, which subsided spontaneously, no serious untoward reactions were reported following Elixir Paregorico® administration. To our knowledge, this is the first demonstration that Elixir Paregorico® administered four times a day for 10 days is safe and does not cause any noticeable toxic effect in healthy volunteers.

Key Words: diarrhea • Elixir Paregorico® • papaver somniferum • safety • tolerability

Human & Experimental Toxicology, Vol. 27, No. 10, 751-756 (2008)
DOI: 10.1177/0960327108090274


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?